dictated by the annual French Social Security Financing Act (LFSS) and subsequent Ministry of Health tariff decrees. Under French statutory law, national healthcare tariff rates for private and public hospitals are published annually in the spring, setting fixed reimbursement fees for surgical admissions, intensive …
Mayne Pharma Group Limited (ASX:MYX) is a specialty pharmaceutical company focused on women’s health, dermatology and pharmaceutical development and manufacturing services. On 14 October 2026, the company announced a significant court decision relating to its disputed proposed transaction with Cosette. The outcome clarifies several …
Epiminder (ASX:EPI) describes DETECT, short for Diagnosing Epilepsy To EffeCT change, as a prospective, randomised, controlled, blinded, multicentre US study. It evaluates whether the Minder System can improve clinical decision-making for people whose extended electroencephalographic, or EEG, monitoring has produced inconclusive findings. The study …
Medical Developments International (ASX:MVP) said chief executive Brent MacGregor intends to leave the role and return to North America. Chief financial officer Anita James was appointed interim chief executive effective 15 October 2026, while MacGregor is scheduled to remain available as an adviser until …
dictated by the annual French Social Security Financing Act (LFSS) and subsequent Ministry of Health tariff decrees. Under French statutory law, national healthcare tariff rates for private and public hospitals are published annually in the spring, setting fixed reimbursement fees for surgical admissions, intensive …
The foundational operational prerequisite governing digital pathology expansion is deploying ultra-high-speed digital slide scanners across all central German laboratory facilities. Specialized robotic scanners digitize physical glass tissue biopsy slides into multi-gigapixel digital images in seconds. Management's documented milestone roadmap requires completing optical scanner installations, …
• The operational sequence governing short-stay hospital expansion is structured around specific property development and medical fit-out milestones.
• The operational timeline governing commercial AI rollouts is anchored to documented regulatory clearance milestones from the US Food and.
The regulatory submission roadmap is governed by documented clinical trial completion milestones. Advanced pipeline candidates—including specialized monoclonal antibodies for autoimmune conditions and recombinant coagulation factors for rare hematological disorders—are progressing through global Phase 3 multi-centre clinical trials. Gating criteria require demonstrating statistically significant superiority …
BLS Pharmaceuticals (ASX:BLS) reported revenue of $26.7 million for the three months ended 30 September 2026, compared with $21.7 million in the June quarter. The updated figure appeared in a revised report released on 15 October 2026 and superseded an inconsistent amount in the …